Publicacións nas que colabora con Miguel González Barcia (44)

2022

  1. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

  2. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery

    Pharmaceutics, Vol. 14, Núm. 4

  3. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 172, pp. 144-156

  4. Evidencia seleccionada y cherry picking en formulación magistral

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 2, pp. 100-101

  5. Design, optimization, and in vitro characterization of idebenone-loaded PLGA microspheres for LHON treatment

    International Journal of Pharmaceutics, Vol. 616

  6. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

2021

  1. Current Situation and Challenges in Vitreous Substitutes

    Macromolecular Bioscience, Vol. 21, Núm. 8

  2. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis

    International Journal of Pharmaceutics, Vol. 597

  3. Impresión 3D de supositorios de tacrolimus para el tratamiento de la colitis ulcerosa

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 273-274

  4. Evaluación preclínica empleando imagen PET/CT de formulaciones impresas en 3D para el tratamiento de la Enfermedad Inflamatoria Intestinal

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 275-276

  5. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 162, pp. 12-22

  6. Diseño, desarrollo y caracterización de nanopartículas de PLGA cargadas con adalimumab

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 63-65

  7. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  8. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  9. Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 168, pp. 195-207

  10. Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan/TPP and Chitosan/Sulfobutylether-β-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 3, pp. 3559-3575

  11. Base preclínica de sistemas lipídicos nanoestructurados (NLC) cargados con bevacizumab: diseño, desarrollo y caracterización fisicoquímica

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 87-89

  12. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  13. 3D printed tacrolimus suppositories for the treatment of ulcerative colitis

    Asian Journal of Pharmaceutical Sciences, Vol. 16, Núm. 1, pp. 110-119

2020

  1. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19